Karen Hale Named Chief Legal and Compliance Officer at Novartis
Novartis announced the appointment of Karen Hale to the expanded role of…
ADPHC and Novartis Team Up to Tackle Chronic Diseases in Abu Dhabi
In a major step to combat non-communicable diseases (NCDs), the Abu Dhabi…
Farabursen Joins Novartis Pipeline in $1.7B Regulus Deal Targeting ADPKD
April 30, 2025 – Basel — Novartis has announced plans to acquire…
Karen Hale Named Chief Legal and Compliance Officer at Novartis
1. After nearly seven years as a member of the Executive Committee…
Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging
December 2024- Siemens Healthineers has concluded the acquisition from Novartis of Advanced…
Novartis’ Fabhalta gets FDA nod for IgAN Treatment
Basel- August 2024- Novartis announced that the U.S. Food and Drug Administration…
DoH-Abu Dhabi and Novartis to Partner to Advance Genomics Research
Abu Dhabi- 7 June 2024- At BIO 2024 International Convention, the Department…
Novartis inaugurates new premises in Egypt
Cairo- February 2024- Leading pharmaceutical company Novartis Pharma S.A.E (Novartis Egypt) officially…
Novartis Appoints Sloan Simpson as Global Head of Investor Relations
February 2024- Novartis announced that Sloan Simpson has been appointed Global Head…
Novartis boosts Pluvicto production with new Indianapolis facility
Basel, Switzerland- January 2024- Novartis has gained approval from the US Food…